ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,770.20
0.55%
Dow Jones
42,801.72
0.52%
US Dollar vs MXN
20.26717
0.00%
Brent Oil
70.235
0.00%
Bitcoin
86,043.22
-0.13%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Ayala Pharmaceuticals Inc (AYLA)

  7. Ayala Pharmaceuticals Inc (AYLA) Noticias

AYLA

Ayala Pharmaceuticals (AYLA)

Ayala Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AYLA
FechaHoraFuenteTítuloSímboloCompañía
08/02/202316:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AYLAAyala Pharmaceuticals Inc
06/02/202313:50Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:AYLAAyala Pharmaceuticals Inc
25/01/202315:54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202309:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202305:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202314:52Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202314:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202314:33Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AYLAAyala Pharmaceuticals Inc
04/11/202215:38Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AYLAAyala Pharmaceuticals Inc
03/11/202215:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202203:46TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202203:45TipRanksNoble Financial Reaffirms Their Hold Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202209:11TipRanksAyala Pharma (NASDAQ:AYLA) Bags fast Track Status for Desmoid Tumor CandidateNASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202207:58Dow Jones NewsAyala Pharmaceuticals Gets Fast-Track Designation for AL102 Cancer TreatmentNASDAQ:AYLAAyala Pharmaceuticals Inc
19/09/202205:25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
13/09/202207:05TipRanksAyala Pharmaceuticals (AYLA) Receives a Buy from Noble FinancialNASDAQ:AYLAAyala Pharmaceuticals Inc
17/08/202207:05TipRanksNoble Financial Keeps Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
16/08/202215:40AllPennyStocks.comQ2 Financial Results Send Micro Cap SoaringNASDAQ:AYLAAyala Pharmaceuticals Inc
27/07/202207:25TipRanksNoble Financial Thinks Ayala Pharmaceuticals’ Stock is Going to RecoverNASDAQ:AYLAAyala Pharmaceuticals Inc
26/07/202213:24TipRanksAyala Pharmaceuticals Stock Nearly Triples on Desmoid Tumor Treatment NewsNASDAQ:AYLAAyala Pharmaceuticals Inc
25/07/202216:21Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/05/202205:26TipRanksH.C. Wainwright Reiterates a Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
17/05/202207:45TipRanksNoble Financial Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/04/202215:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AYLAAyala Pharmaceuticals Inc
30/03/202205:35TipRanksAnalysts Conflicted on These Healthcare Names: Acelrx (ACRX) and Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
28/03/202212:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
09/03/202205:24TipRanksH.C. Wainwright Thinks Ayala Pharmaceuticals’ Stock is Going to RecoverNASDAQ:AYLAAyala Pharmaceuticals Inc
04/02/202208:17Edgar (US Regulatory)Schedule 13gNASDAQ:AYLAAyala Pharmaceuticals Inc
17/01/202216:14TipRanksBuy These 2 Small-Cap Stocks to Double Your Investment, Say AnalystsNASDAQ:AYLAAyala Pharmaceuticals Inc
15/11/202107:00GlobeNewswire Inc.Ayala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:AYLAAyala Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AYLA

Su Consulta Reciente

AMEX
XLE
Energy Select Sector SPDR
AMEX
XLF
Financial Select Sector
FX
EURUSD
Euro vs US Dollar
USI
USTECH100
US Tech 100
NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
PM
XAUUSD
Gold vs US Dollar
NASDAQ
AAPL
Apple
COIN
ETHUSD
Ethereum
CCOM
US500
US 500
COIN
ADAUSD
Cardano
NASDAQ
MSFT
Microsoft
NYSE
CVX
Chevron
COIN
DOGEUSD
Dogecoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios